Patrick joined the Board in 2016 as Non-Executive Chairman. He spent over three years at Cubist Pharmaceuticals, which he joined in 2012 as SVP and head of international business operations, and where afterwards he served as EVP and COO. Prior to joining Cubist, Patrick served as SVP, global head of hospital business and global head of biologics at Mylan Inc., which he joined in 2008, helping to establish the company's operations in Switzerland. Patrick has held several leadership positions across the pharmaceutical industry, including head of global business franchise biopharmaceuticals for Novartis Sandoz; vice president for international business for Biogen; and head of worldwide marketing, cardiovascular and thrombosis for Sanofi-Synthelabo. Patrick served as a member of the executive committee of the European Federation of Pharmaceutical Industries and Associations (EFPIA) between 2013 and 2015. He is currently active as an advisor to the Life Sciences sector and serves as a member of the board of directors of several companies including Concordia International Corp, Piqur AG and Spero Therapeutics.